FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
11.58
+0.27 (2.39%)
Sep 5, 2025, 12:35 PM - Market open
FibroGen Market Cap
FibroGen has a market cap or net worth of $46.83 million as of September 5, 2025. Its market cap has increased by 27.60% in one year.
Market Cap
46.83M
Enterprise Value
115.50M
1-Year Change
27.60%
Ranking
Category
Stock Price
$11.58
Market Cap Chart
Since November 14, 2014, FibroGen's market cap has decreased from $1.22B to $46.83M, a decrease of -96.18%. That is a compound annual growth rate of -26.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 48.40M | -9.36% |
| Dec 31, 2024 | 53.40M | -38.76% |
| Dec 29, 2023 | 87.20M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
| Nov 14, 2014 | 1.22B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.01B |
| Johnson & Johnson | 428.83B |
| AbbVie | 374.37B |
| UnitedHealth Group | 279.67B |
| Novo Nordisk | 248.91B |
| AstraZeneca | 247.16B |
| Novartis AG | 244.04B |
| Abbott Laboratories | 228.80B |